Shrivastava Amresh, Johnston Megan, Terpstra Kristen, Bureau Yves
Department of Psychiatry, Elgin Prevention and Early Intervention Program for Psychosis, The University of Western Ontario, and Mental Health Resource Foundation, Ontario, Canada, Mumbai, Maharashtra, India.
Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
Clin Schizophr Relat Psychoses. 2015 Apr;9(1):30-5. doi: 10.3371/CSRP.SHJO.030813.
Cannabis has been implicated as a risk factor for the development of schizophrenia, but the exact biological mechanisms remain unclear. In this review, we attempt to understand the neurobiological pathways that link cannabis use to schizophrenia. This has been an area of great debate; despite similarities between cannabis users and schizophrenia patients, the evidence is not sufficient to establish cause-and-effect. There have been advances in the understanding of the mechanisms of cannabis dependence as well as the role of the cannabinoid system in the development of psychosis and schizophrenia. The neurobiological mechanisms associated with the development of psychosis and effects from cannabis use may be similar but remain elusive. In order to better understand these associations, this paper will show common neurobiological and neuroanatomical changes as well as common cognitive dysfunction in cannabis users and patients of schizophrenia. We conclude that epidemiologic evidence highlights potential causal links; however, neurobiological evidence for causality remains weak.
大麻已被认为是精神分裂症发病的一个风险因素,但确切的生物学机制仍不清楚。在本综述中,我们试图了解将大麻使用与精神分裂症联系起来的神经生物学途径。这一直是一个备受争议的领域;尽管大麻使用者和精神分裂症患者之间存在相似之处,但证据不足以确立因果关系。在对大麻依赖机制以及大麻素系统在精神病和精神分裂症发展中的作用的理解方面已经取得了进展。与精神病发展和大麻使用影响相关的神经生物学机制可能相似,但仍难以捉摸。为了更好地理解这些关联,本文将展示大麻使用者和精神分裂症患者常见的神经生物学和神经解剖学变化以及常见的认知功能障碍。我们得出结论,流行病学证据突出了潜在的因果联系;然而,因果关系的神经生物学证据仍然薄弱。